(BILS) Series Trust - Bloomberg - Overview
Etf: Treasury Bills, Sampling Portfolio, 3-12 Month, ETF
Dividends
| Dividend Yield | 4.38% |
| Yield on Cost 5y | 4.67% |
| Yield CAGR 5y | 36.23% |
| Payout Consistency | 95.5% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 4.74% |
| Relative Tail Risk | 12.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.04 |
| Alpha | 0.11 |
| Character TTM | |
|---|---|
| Beta | -0.003 |
| Beta Downside | -0.003 |
| Drawdowns 3y | |
|---|---|
| Max DD | 0.07% |
| CAGR/Max DD | 73.49 |
Description: BILS Series Trust - Bloomberg January 11, 2026
The SPDR Bloomberg Barclays 3-12 Month T-Bill ETF (BILS) seeks to replicate the Bloomberg Barclays U.S. Treasury 3-12 Month Index by using a sampling methodology, meaning it holds a representative subset of the Treasury bills rather than every issue in the index.
Key characteristics: the fund’s average weighted maturity is roughly 0.6 years, giving it an effective duration near 0.2, which makes its price relatively insensitive to short-term interest-rate moves. As of the latest reporting, the expense ratio stands at 0.05 %, and the 30-day SEC yield is about 5.1 %, reflecting current Fed policy rates and Treasury bill auction results. The ETF’s liquidity is high, with an average daily trading volume exceeding 150 k shares and a bid-ask spread typically under 0.5 bps, supporting efficient execution for investors seeking ultra-short exposure.
Given the fund’s focus on Treasury bills, its performance is primarily driven by the Federal Reserve’s short-term rate stance, the supply of newly-issued T-bills at auction, and macro-economic indicators such as the weekly jobless claims report, which influence market expectations for rate changes.
For a deeper quantitative dive into BILS’s risk-adjusted returns and scenario analysis, you might explore the ValueRay platform’s interactive toolkit.
What is the price of BILS shares?
Over the past week, the price has changed by +0.06%, over one month by +0.27%, over three months by +0.95% and over the past year by +4.16%.
Is BILS a buy, sell or hold?
What are the forecasts/targets for the BILS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 109 | 9.9% |
BILS Fundamental Data Overview February 05, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 3.88b USD (3.88b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 3.88b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 3.88b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 5.90% (E(3.88b)/V(3.88b) * Re(5.90%) + (debt-free company))
Discount Rate = 5.90% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)